High-throughput peptide arrays identify potential diagnostic autoantibody signatures in early-stage lung adenocarcinoma.

Rongrong Luo Pei Zhong Xiying Li Juan Cai Yimin Tao Bangzhu Xiong Hancheng Zheng Zhishang Zhang Le Tang Jiarui Yao Yingrui Li Yuan-Kai Shi Xiao-Hong Han

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)

Novel sensitive autoantibody signatures can adjuvant LDCT to better diagnose LUAD at very-early-stage.

Keyphrases

early stage
high throughput
genome wide
sentinel lymph node
single cell
squamous cell carcinoma
gene expression
risk assessment